The latest update from the U.S. Food and Drug Administration highlights a series of concerning drug recalls, manufacturing violations, and quality control failures that could affect commonly prescribed medications in the United States. This installment focuses on recalls involving a blood pressure drug, a widely used opioid pain reliever, and an antidepressant, along with warning letters issued to three pharmaceutical manufacturing and compounding facilities for serious regulatory breaches.

Together, these actions underscore the FDA’s ongoing effort to monitor medication safety, enforce manufacturing standards, and protect patients from potential harm related to contaminated, mislabeled, or improperly produced drugs.

Drug Recalls: Quality, Contamination, and Mix-Ups

The FDA classifies recalls based on the severity of potential health risks. Class I recalls represent the most serious situations, involving products that may cause serious injury or death. Class II recalls indicate products that may cause temporary or medically reversible health issues, while Class III recalls involve products unlikely to cause adverse health consequences.

Blood Pressure Medication Recalled Over Cancer-Linked Impurities

A combination blood pressure medication containing bisoprolol fumarate and hydrochlorothiazide—commonly prescribed to treat hypertension—has been recalled due to the presence of nitrosamine impurities above FDA-recommended limits. Nitrosamines are chemical compounds that may increase cancer risk when consumed over time.

The affected medication, manufactured by Unichem Pharmaceuticals USA Inc. and produced in Goa, India, was distributed in 100-count bottles of 2.5 mg/6.25 mg tablets. Although the recall is classified as Class II and is directed at the supplier level, patients may still wish to verify whether their prescription matches the recalled lot numbers and expiration dates listed in FDA enforcement reports.

Opioid Painkiller Recall Due to Tablet Identification Failures

Another Class II recall involves oxycodone-acetaminophen tablets, a commonly prescribed opioid combination used to treat moderate to severe pain when alternative treatments are insufficient. The recall affects nearly 362,000 bottles of tablets in two dosage strengths—10 mg/325 mg and 7.5 mg/325 mg—manufactured by SpecGx, LLC.<<<…CONTINUE READING…>>>